Ecraid
@ecraid.bsky.social
The European Clinical Research Alliance for Infectious Diseases is a not-for profit foundation that advances clinical research in infectious diseases.
Today in #InternationalEducationDay
Ecraid is more than an organisation focused on clinical research. It is a place where young and early-career talent and experienced experts – from both academia and industry – connect to collaborate and learn.
Explore our Education Page: ecraid.eu/education
Ecraid is more than an organisation focused on clinical research. It is a place where young and early-career talent and experienced experts – from both academia and industry – connect to collaborate and learn.
Explore our Education Page: ecraid.eu/education
January 24, 2026 at 9:00 AM
Today in #InternationalEducationDay
Ecraid is more than an organisation focused on clinical research. It is a place where young and early-career talent and experienced experts – from both academia and industry – connect to collaborate and learn.
Explore our Education Page: ecraid.eu/education
Ecraid is more than an organisation focused on clinical research. It is a place where young and early-career talent and experienced experts – from both academia and industry – connect to collaborate and learn.
Explore our Education Page: ecraid.eu/education
📣 The first site has been activated in the PIPELINE-RSV International trial & is now open for recruitment at St George's University Hospitals NHS Foundation Trust in London!
Congratulations to everyone involved in reaching this important milestone!
#RSV #Vaccination #MonoclonalAntibodies #mAbs
Congratulations to everyone involved in reaching this important milestone!
#RSV #Vaccination #MonoclonalAntibodies #mAbs
January 22, 2026 at 8:39 AM
📣 The first site has been activated in the PIPELINE-RSV International trial & is now open for recruitment at St George's University Hospitals NHS Foundation Trust in London!
Congratulations to everyone involved in reaching this important milestone!
#RSV #Vaccination #MonoclonalAntibodies #mAbs
Congratulations to everyone involved in reaching this important milestone!
#RSV #Vaccination #MonoclonalAntibodies #mAbs
🚨 Last Call: Ecraid Foundation Science Meeting!
Today is your final chance to register for this academic event bringing together leading experts from academia, industry, and the public sector. Can’t attend this time?
You can still stay connected! Subscribe to our newsletter: bit.ly/EcraidJan26
Today is your final chance to register for this academic event bringing together leading experts from academia, industry, and the public sector. Can’t attend this time?
You can still stay connected! Subscribe to our newsletter: bit.ly/EcraidJan26
January 21, 2026 at 10:52 AM
🚨 Last Call: Ecraid Foundation Science Meeting!
Today is your final chance to register for this academic event bringing together leading experts from academia, industry, and the public sector. Can’t attend this time?
You can still stay connected! Subscribe to our newsletter: bit.ly/EcraidJan26
Today is your final chance to register for this academic event bringing together leading experts from academia, industry, and the public sector. Can’t attend this time?
You can still stay connected! Subscribe to our newsletter: bit.ly/EcraidJan26
📢 Ecraid Foundation Science Meeting: registration deadline extended! Join industry leaders, researchers, clinicians & policy experts to discuss cutting-edge science & collaboration in infectious diseases and clinical research.
Accredited by NVMM (11 points) and ABIC
www.eventbrite.nl/e/ecraid-fou...
Accredited by NVMM (11 points) and ABIC
www.eventbrite.nl/e/ecraid-fou...
Ecraid Foundation Science Meeting
Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.
www.eventbrite.nl
January 16, 2026 at 3:22 PM
📢 Ecraid Foundation Science Meeting: registration deadline extended! Join industry leaders, researchers, clinicians & policy experts to discuss cutting-edge science & collaboration in infectious diseases and clinical research.
Accredited by NVMM (11 points) and ABIC
www.eventbrite.nl/e/ecraid-fou...
Accredited by NVMM (11 points) and ABIC
www.eventbrite.nl/e/ecraid-fou...
Read this research letter on the re-emergence of M. pneumoniae 👉 publications.ersnet.org/content/erjo...
This unexpected surge emphasises the need for continued attention to respiratory #pathogen dynamics and their impact on #PatientCare and #PublicHealth responses.
@europeanrespsoc.bsky.social
This unexpected surge emphasises the need for continued attention to respiratory #pathogen dynamics and their impact on #PatientCare and #PublicHealth responses.
@europeanrespsoc.bsky.social
January 14, 2026 at 1:41 PM
Read this research letter on the re-emergence of M. pneumoniae 👉 publications.ersnet.org/content/erjo...
This unexpected surge emphasises the need for continued attention to respiratory #pathogen dynamics and their impact on #PatientCare and #PublicHealth responses.
@europeanrespsoc.bsky.social
This unexpected surge emphasises the need for continued attention to respiratory #pathogen dynamics and their impact on #PatientCare and #PublicHealth responses.
@europeanrespsoc.bsky.social
📢 Programme Update: Meet our Speakers!
We’ve added new speakers to the Ecraid Foundation Science Meeting - each track now features a detailed programme. Featured speakers include: Pontus Naucler (Karolinska Institute) Kristina Rudd (Pittsburgh University) & industry leaders.
👉🏼 Register: bit.ly/EFSM
We’ve added new speakers to the Ecraid Foundation Science Meeting - each track now features a detailed programme. Featured speakers include: Pontus Naucler (Karolinska Institute) Kristina Rudd (Pittsburgh University) & industry leaders.
👉🏼 Register: bit.ly/EFSM
Ecraid Foundation Science Meeting
Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.
bit.ly
January 13, 2026 at 12:25 PM
📢 Programme Update: Meet our Speakers!
We’ve added new speakers to the Ecraid Foundation Science Meeting - each track now features a detailed programme. Featured speakers include: Pontus Naucler (Karolinska Institute) Kristina Rudd (Pittsburgh University) & industry leaders.
👉🏼 Register: bit.ly/EFSM
We’ve added new speakers to the Ecraid Foundation Science Meeting - each track now features a detailed programme. Featured speakers include: Pontus Naucler (Karolinska Institute) Kristina Rudd (Pittsburgh University) & industry leaders.
👉🏼 Register: bit.ly/EFSM
🤧 The EU-funded #ECRAIDPrime trial has randomised its first 3 remote patients in the #UK this flu season — launching a patient-centric approach to expand access and community participation. This is a big step for infectious disease trials in #PrimaryCare and #Europe. 🎉 Congrats to the Oxford team!
January 12, 2026 at 2:25 PM
🤧 The EU-funded #ECRAIDPrime trial has randomised its first 3 remote patients in the #UK this flu season — launching a patient-centric approach to expand access and community participation. This is a big step for infectious disease trials in #PrimaryCare and #Europe. 🎉 Congrats to the Oxford team!
Europe’s first #adaptiveplatformtrial for #COVID19 and COVID-like illness in the community launched its third treatment arm, marking an important step forward in Europe's pandemic preparedness. Read about this pioneering trial on www.ecraid.eu/news/primary...
Primary Care Platform Trial for Respiratory Infections Launches Third Treatment Arm | Ecraid
www.ecraid.eu
January 8, 2026 at 2:40 PM
Europe’s first #adaptiveplatformtrial for #COVID19 and COVID-like illness in the community launched its third treatment arm, marking an important step forward in Europe's pandemic preparedness. Read about this pioneering trial on www.ecraid.eu/news/primary...
3 years on, Ecraid is firmly embedded in Europe’s infectious diseases research ecosystem. In this interview with Prof. Sir @peterhorby.bsky.social from the Pandemic Sciences Institute, Oxford, he discusses Ecraid’s clinical trial infrastructure & future challenges. www.ecraid.eu/articles/eur...
From Europe to the World: Insights from Peter Horby | Ecraid
An interview with Peter Horby about Ecraid’s unique clinical trial infrastructure, and the opportunities and challenges ahead.
www.ecraid.eu
January 7, 2026 at 1:55 PM
3 years on, Ecraid is firmly embedded in Europe’s infectious diseases research ecosystem. In this interview with Prof. Sir @peterhorby.bsky.social from the Pandemic Sciences Institute, Oxford, he discusses Ecraid’s clinical trial infrastructure & future challenges. www.ecraid.eu/articles/eur...
🚨 The countdown is on for the Ecraid Foundation Science Meeting 2026! Join us for high-impact scientific exchange and collaborative networking.
🥼 Access to infectious disease experts
🏆 Accreditation by ABIC and NVMM
Don’t miss your chance to register: www.eventbrite.nl/e/ecraid-fou...
🥼 Access to infectious disease experts
🏆 Accreditation by ABIC and NVMM
Don’t miss your chance to register: www.eventbrite.nl/e/ecraid-fou...
Ecraid Foundation Science Meeting
Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.
www.eventbrite.nl
December 31, 2025 at 8:41 AM
🚨 The countdown is on for the Ecraid Foundation Science Meeting 2026! Join us for high-impact scientific exchange and collaborative networking.
🥼 Access to infectious disease experts
🏆 Accreditation by ABIC and NVMM
Don’t miss your chance to register: www.eventbrite.nl/e/ecraid-fou...
🥼 Access to infectious disease experts
🏆 Accreditation by ABIC and NVMM
Don’t miss your chance to register: www.eventbrite.nl/e/ecraid-fou...
🎧Recording available!
Tune into this webinar in collaboration with @europeanrespsoc.bsky.social on #PandemicPreparedness 👇
channel.ersnet.org/media-114951...
Tune into this webinar in collaboration with @europeanrespsoc.bsky.social on #PandemicPreparedness 👇
channel.ersnet.org/media-114951...
December 29, 2025 at 11:19 AM
🎧Recording available!
Tune into this webinar in collaboration with @europeanrespsoc.bsky.social on #PandemicPreparedness 👇
channel.ersnet.org/media-114951...
Tune into this webinar in collaboration with @europeanrespsoc.bsky.social on #PandemicPreparedness 👇
channel.ersnet.org/media-114951...
As we close out 2025, we look back on a truly landmark year for Ecraid: one defined by growth, collaboration, and impact. Thank you to our partners, collaborators, sites, investigators, and team members for your commitment and trust.
Happy holidays, and all the best for the year ahead 🌟
Happy holidays, and all the best for the year ahead 🌟
December 24, 2025 at 9:02 AM
As we close out 2025, we look back on a truly landmark year for Ecraid: one defined by growth, collaboration, and impact. Thank you to our partners, collaborators, sites, investigators, and team members for your commitment and trust.
Happy holidays, and all the best for the year ahead 🌟
Happy holidays, and all the best for the year ahead 🌟
🎉 Amazing milestones reached in three of our perpetual observational studies (POS)! We are tremendously proud of ALL the site teams behind these studies, for making it happen as 2025 comes to an end - a great way to wrap up the year!
Thank you!
ecraid.eu/ecraid-base/...
Thank you!
ecraid.eu/ecraid-base/...
December 23, 2025 at 9:30 AM
🎉 Amazing milestones reached in three of our perpetual observational studies (POS)! We are tremendously proud of ALL the site teams behind these studies, for making it happen as 2025 comes to an end - a great way to wrap up the year!
Thank you!
ecraid.eu/ecraid-base/...
Thank you!
ecraid.eu/ecraid-base/...
Announcing Module 2 of the Ecraid x @ESCMID online course on Biomedical Data & Sample Governance: 'How to design your data governance framework' in collaboration with CoMeCT, IDDO, CERCLE, @who.int and @tghn-news.bsky.social
🎧👉 www.escmid.org/education/ed...
#DataGovernance #EpidemicPreparedness
🎧👉 www.escmid.org/education/ed...
#DataGovernance #EpidemicPreparedness
December 22, 2025 at 12:28 PM
Announcing Module 2 of the Ecraid x @ESCMID online course on Biomedical Data & Sample Governance: 'How to design your data governance framework' in collaboration with CoMeCT, IDDO, CERCLE, @who.int and @tghn-news.bsky.social
🎧👉 www.escmid.org/education/ed...
#DataGovernance #EpidemicPreparedness
🎧👉 www.escmid.org/education/ed...
#DataGovernance #EpidemicPreparedness
📩Our final newsletter of 2025 is out!
As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard!
Read more & subscribe: bit.ly/Dec25Ecraid
As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard!
Read more & subscribe: bit.ly/Dec25Ecraid
December 18, 2025 at 1:18 PM
📩Our final newsletter of 2025 is out!
As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard!
Read more & subscribe: bit.ly/Dec25Ecraid
As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard!
Read more & subscribe: bit.ly/Dec25Ecraid
The rationale & design of the #PNEUMO study Europe was recently published!
👉 bit.ly/3MBR6d4
Now in its final year, the studies primary goal is to estimate the incidence of pneumococcal #pneumonia & serotype prevalence among adults in Europe.
#ClinicalTrials #InfectiousDiseases #ResearchSky #IDSky
👉 bit.ly/3MBR6d4
Now in its final year, the studies primary goal is to estimate the incidence of pneumococcal #pneumonia & serotype prevalence among adults in Europe.
#ClinicalTrials #InfectiousDiseases #ResearchSky #IDSky
December 16, 2025 at 8:16 AM
The rationale & design of the #PNEUMO study Europe was recently published!
👉 bit.ly/3MBR6d4
Now in its final year, the studies primary goal is to estimate the incidence of pneumococcal #pneumonia & serotype prevalence among adults in Europe.
#ClinicalTrials #InfectiousDiseases #ResearchSky #IDSky
👉 bit.ly/3MBR6d4
Now in its final year, the studies primary goal is to estimate the incidence of pneumococcal #pneumonia & serotype prevalence among adults in Europe.
#ClinicalTrials #InfectiousDiseases #ResearchSky #IDSky
Join the Ecraid Foundation Science Meeting on 2 February 2026 in Utrecht! This two-day academic event brings together leading experts, researchers & infectious disease opinion leaders from across Europe to advance clinical research in ID.
More info & tickets: www.eventbrite.nl/e/ecraid-fou...
More info & tickets: www.eventbrite.nl/e/ecraid-fou...
Ecraid Foundation Science Meeting
Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.
www.eventbrite.nl
December 15, 2025 at 1:20 PM
Join the Ecraid Foundation Science Meeting on 2 February 2026 in Utrecht! This two-day academic event brings together leading experts, researchers & infectious disease opinion leaders from across Europe to advance clinical research in ID.
More info & tickets: www.eventbrite.nl/e/ecraid-fou...
More info & tickets: www.eventbrite.nl/e/ecraid-fou...
Trainings, talent & top science: the last Ecraid Learning Newsletter of the year is out!
Filled to the brim with exciting courses, testimonials from participants at past ones, freshly-published science and interesting interviews & blogs!
👉🏽https://bit.ly/LearningDecEcraid
Filled to the brim with exciting courses, testimonials from participants at past ones, freshly-published science and interesting interviews & blogs!
👉🏽https://bit.ly/LearningDecEcraid
December 15, 2025 at 9:48 AM
Trainings, talent & top science: the last Ecraid Learning Newsletter of the year is out!
Filled to the brim with exciting courses, testimonials from participants at past ones, freshly-published science and interesting interviews & blogs!
👉🏽https://bit.ly/LearningDecEcraid
Filled to the brim with exciting courses, testimonials from participants at past ones, freshly-published science and interesting interviews & blogs!
👉🏽https://bit.ly/LearningDecEcraid
Ecraid joins the #PrIMAVeRa_AMR Consortium to accelerate #AMR modelling!
This strategic partnership is a powerful step forward in the fight against #AntimicrobialResistance.
👉🏽Learn more about this vital collaboration & its impact on public health: www.ecraid.eu/news/ecraid-...
#StopSuperbugs
This strategic partnership is a powerful step forward in the fight against #AntimicrobialResistance.
👉🏽Learn more about this vital collaboration & its impact on public health: www.ecraid.eu/news/ecraid-...
#StopSuperbugs
December 10, 2025 at 1:33 PM
Ecraid joins the #PrIMAVeRa_AMR Consortium to accelerate #AMR modelling!
This strategic partnership is a powerful step forward in the fight against #AntimicrobialResistance.
👉🏽Learn more about this vital collaboration & its impact on public health: www.ecraid.eu/news/ecraid-...
#StopSuperbugs
This strategic partnership is a powerful step forward in the fight against #AntimicrobialResistance.
👉🏽Learn more about this vital collaboration & its impact on public health: www.ecraid.eu/news/ecraid-...
#StopSuperbugs
Ventilator-associated pneumonia can be a challenge to study in traditional randomised controlled trials due to low patient and event numbers. This recent paper explores whether adaptive trial designs can make VAP prevention trials more efficient
link.springer.com/article/10.1...
link.springer.com/article/10.1...
December 4, 2025 at 1:03 PM
Ventilator-associated pneumonia can be a challenge to study in traditional randomised controlled trials due to low patient and event numbers. This recent paper explores whether adaptive trial designs can make VAP prevention trials more efficient
link.springer.com/article/10.1...
link.springer.com/article/10.1...
Proud to be a part of the PrIMAVeRA consortium and contribute to developing comprehensive mathematical models to predict the impact of #vaccines and mAbs on reducing the burden of #anitmicrobialresistance 👇 🎉
🤝 The #PrIMAVeRa_AMR consortium welcomes its newest partner: the European Clinical Research Alliance on Infectious Diseases (@ecraid.bsky.social)!
🔗 Read more: www.primavera-amr.eu/post/ecraid-...
#EUfunded @ihieurope.bsky.social @ecraid.bsky.social
🔗 Read more: www.primavera-amr.eu/post/ecraid-...
#EUfunded @ihieurope.bsky.social @ecraid.bsky.social
Ecraid becomes the newest member of the PrIMAVeRa Consortium
PrIMAVeRa welcomes Ecraid, the newest member of the project consortium.
www.primavera-amr.eu
November 20, 2025 at 1:51 PM
Proud to be a part of the PrIMAVeRA consortium and contribute to developing comprehensive mathematical models to predict the impact of #vaccines and mAbs on reducing the burden of #anitmicrobialresistance 👇 🎉
📩 Our latest newsletter is out! We’re thrilled to welcome our new CEO, @lenniederde.bsky.social, marking a fresh chapter in Ecraid’s journey. Other updates in this edition:
✅ ECRAID-Base: new publications
✅ ECRAID-Prime: launch of third treatment arm
And more…
📫 Subscribe now: bit.ly/NovEcraid
✅ ECRAID-Base: new publications
✅ ECRAID-Prime: launch of third treatment arm
And more…
📫 Subscribe now: bit.ly/NovEcraid
November 13, 2025 at 1:31 PM
📩 Our latest newsletter is out! We’re thrilled to welcome our new CEO, @lenniederde.bsky.social, marking a fresh chapter in Ecraid’s journey. Other updates in this edition:
✅ ECRAID-Base: new publications
✅ ECRAID-Prime: launch of third treatment arm
And more…
📫 Subscribe now: bit.ly/NovEcraid
✅ ECRAID-Base: new publications
✅ ECRAID-Prime: launch of third treatment arm
And more…
📫 Subscribe now: bit.ly/NovEcraid
We are very pleased to announce Lennie Derde as Ecraid's new Chief Executive Officer effective 1 January 2026. She will succeed Ecraid’s co-founder @marcbonten.bsky.social
Read more 👉 ecraid.eu/articles/len...
@umcutrecht.bsky.social @ec.europa.eu @horizoneu.bsky.social
Read more 👉 ecraid.eu/articles/len...
@umcutrecht.bsky.social @ec.europa.eu @horizoneu.bsky.social
November 12, 2025 at 1:43 PM
We are very pleased to announce Lennie Derde as Ecraid's new Chief Executive Officer effective 1 January 2026. She will succeed Ecraid’s co-founder @marcbonten.bsky.social
Read more 👉 ecraid.eu/articles/len...
@umcutrecht.bsky.social @ec.europa.eu @horizoneu.bsky.social
Read more 👉 ecraid.eu/articles/len...
@umcutrecht.bsky.social @ec.europa.eu @horizoneu.bsky.social
💉Early BCG vaccination could save newborn lives. A new RCT from India shows a nearly 20% drop in neonatal mortality simply by administering vaccines earlier.
🔗 Read the latest blog post by @marcbonten.bsky.social: letstalkscience.eu/2025/11/04/l...
Join the discussion 👇🏽
🔗 Read the latest blog post by @marcbonten.bsky.social: letstalkscience.eu/2025/11/04/l...
Join the discussion 👇🏽
November 7, 2025 at 8:57 AM
💉Early BCG vaccination could save newborn lives. A new RCT from India shows a nearly 20% drop in neonatal mortality simply by administering vaccines earlier.
🔗 Read the latest blog post by @marcbonten.bsky.social: letstalkscience.eu/2025/11/04/l...
Join the discussion 👇🏽
🔗 Read the latest blog post by @marcbonten.bsky.social: letstalkscience.eu/2025/11/04/l...
Join the discussion 👇🏽
💡 The Penta BFA provides recognition & funding to individuals driving change in maternal & child health. Honour a leader who is advancing equitable health outcomes & combatting infectious disease.
Deadline for nominations has been extended to 15 November!
👉🏼 Submit your nomination: penta-id.org/bfa/
Deadline for nominations has been extended to 15 November!
👉🏼 Submit your nomination: penta-id.org/bfa/
Incredible nominations are already coming in for #BFA2025 & we can’t wait to celebrate more champions.
Our past Penta BFA winners prove that local heroes can change global health.
Entries close 15 November.
Nominate your hero today! www.penta-id.org/bfa
Our past Penta BFA winners prove that local heroes can change global health.
Entries close 15 November.
Nominate your hero today! www.penta-id.org/bfa
November 6, 2025 at 10:48 AM
💡 The Penta BFA provides recognition & funding to individuals driving change in maternal & child health. Honour a leader who is advancing equitable health outcomes & combatting infectious disease.
Deadline for nominations has been extended to 15 November!
👉🏼 Submit your nomination: penta-id.org/bfa/
Deadline for nominations has been extended to 15 November!
👉🏼 Submit your nomination: penta-id.org/bfa/